US 9951132
Anti-prokineticin receptor (PROKR) antibodies and uses thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 9951132 (Anti-prokineticin receptor (PROKR) antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/04